Phone Whasapp

S3V VASCULAR TECHNOLOGIES LIMITED Pre IPO Shares, Buy/ Sell S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Shares, S3V VASCULAR TECHNOLOGIES LIMITED Share Price, S3V VASCULAR TECHNOLOGIES LIMITED Unlisted Share price

S3V VASCULAR TECHNOLOGIES LIMITED

COMPANY NAME S3V VASCULAR TECHNOLOGIES LIMITED
NATURE OF BUSINESS MEDICAL DEVICES
ISIN NO INE0HGT01012
FACE VALUE Rs.10/-
PROMOTERS VIJAYA GOPAL NAGARAGADDE
COMPANY WEBSITE www.s3vvascular.com
YEAR OF ESTABLISHMENT 2011
REGISTERED ADDRESS PLOT NO 65-D4, HOOTAGALLI INDUSTRIAL AREA, HOOTAGALLI, MYSORE KARNATAKA INDIA 570018

BOARD OF DIRECTORS

Mr. VIJAYA GOPAL NAGARADAGADDE (MANAGING DIRECTOR)
Mr. BADARI NARAYAN NAGARADA GADDE (WHOLE TIME DIRECTOR & CEO)
Mr. NAGARADA GADDE VISHNU SHREYAS (WHOLE TIME DIRECTOR & CFO)
Mr. NARAYAN KALINDHI (DIRECTOR)

S3V Vascular Technologies Limited is an innovative, research-driven Indian medical device manufacturing company dedicated to designing, developing, and producing advanced vascular, neuro-intervention, and minimally invasive therapeutic devices. Focused on bridging gaps in domestic high-end medical care, S3V specializes in high-precision products such as coronary stents, catheters, balloon dilatation devices, and specialized neurovascular systems. Operating state-of-the-art cleanroom manufacturing facilities equipped with advanced laser cutting, polymer processing, and stringent quality-testing infrastructure, the company emphasizes indigenous med-tech innovation. Backed by prominent industry leaders and institutional supporters (such as the Technology Development Board under the Department of Science and Technology, Government of India), S3V is committed to reducing import dependency in critical healthcare segments, delivering world-class, cost-effective life-saving solutions for cardiovascular and neurological disorders globally.

While strengthening its domestic footprint across premier multi-specialty hospitals and tier-1 healthcare chains, S3V exports its specialized medical apparatus to multiple international markets. By aligning its production scaling with national health insurance schemes (such as Ayushman Bharat), the company continues to drive its core mission: delivering safe, reliable, and cutting-edge medical technology to save lives globally.


Products of Company

  • • Coronary Stent Systems: High-performance drug-eluting and bare-metal stents engineered for optimal vessel scaffolding and endothelial healing.
  • • Neuro-Intervention Devices: Specialized micro catheters, flow diverters, and coil systems designed for minimally invasive stroke and brain aneurysm treatments.
  • • Balloon Catheters: PTCA balloon catheters and high-pressure dilatation tools utilized in complex angioplasty procedures.
  • • Diagnostic & Therapeutic Access Tools: High-precision guide catheters, introducer sheaths, and diagnostic wires facilitating smooth vascular access.

Upcoming Projects

  • • India's First Neuro-Intervention Integrated Manufacturing Plant: Setting up a dedicated, high-tech manufacturing unit in collaboration with the Technology Development Board (TDB) for advanced stroke and neuro-vascular treatment devices.
  • • Global Regulatory Scaling (USFDA & CE Certification): Expanding clinical trials and documentation infrastructure to secure broad USFDA approvals and CE markings for next-generation neuro and coronary portfolios.
  • • Ayushman Bharat Reimbursement Integration: Scaling up production lines and distribution channels to integrate high-end indigenous medical devices into government healthcare reimbursement schemes.

Awards & Recognitions

  • • National Technology Award – Department of Science and Technology, Government of India (2020)
  • • Excellence in Indigenous Medical Technology & Healthcare Innovation Recognition – ET HealthWorld Awards (2023)
  • • Best Med-Tech Enterprise / Startup Honors – Indian MedTech Summit & Excellence Awards (2022)
  • • Quality Manufacturing & R&D Excellence Award – Karnataka State Industrial and Infrastructure Development Corporation (KSIIDC) Recognition (2021)

NEWS